Buoyant Sales Growth
KAEF posted the buoyant growth within three consecutive quarters in the start of 2017. Its sales edged up 5% y-y in 1Q17, moved higher 6% y-y 2Q17, and amplified into 13% y-y in 3Q17. The mood in sales was buoyant as the ethical medicines and OTC divisions respectively posted upbeat sales of 36% y-y, and 23% y-y in 3Q17.
Increment in Profit Margin
Not only did KAEF post a fantastic sales performance, it also posted an increment in gross profit margin from 32% in 9M2016 into 35% in 9M2017. Its success in performing efficiency and trimming the portion of finished-goods purchasing cost to the sales from 55% in 9M2016 into 53% in 9M2017 underlined the increment in gross margin.
Download full report HERE.
